Shares of AXT Inc plunged to $94.57 on June 5, wiping out weeks of gains as a one-two punch of large insider stock sales by CEO Morris Young and a brutal semiconductor sector rout rattled investor confidence in the compound semiconductor substrate maker. AXT Shares Crater 10.8% as CEO Dumps $22 Million in Stock Days Before a Semiconductor Rout — Smart Liquidity or a Warning Sign?
Shares of AXT Inc plunged 10.8% to $94.57 on June 5, hammered by a toxic combination: the CEO cashed out nearly $22.3 million in stock just days before a sector-wide chip selloff erased hundreds of billions in semiconductor market value. The drop leaves AXTI down roughly 30% from its all-time high of $143.16 and raises pointed questions about whether the stock's extraordinary run — over 6,000% in the past year — is running out of fuel.
• The CEO Sold Big, and the Timing Looks Terrible. CEO Morris Young sold 197,498 shares across June 1–2 at weighted average prices of $112.39 and $113.33 per share , exercising options originally granted in 2016 at just $5.21 a share . That's a roughly 2,100% gain on the options alone. He still holds over 2.1 million shares directly , and this followed a separate March sale of 30,832 shares for $1.4 million . While exercise-and-sell transactions can be routine, cumulative dispositions of $24 million in three months signal a leader monetizing gains aggressively — something the market reads as a confidence check on valuation.
• A Sector Storm Made a Bad Headline Worse. Broadcom faced a significant selloff on June 5 after disappointing AI chip sales forecasts , dragging the Philadelphia Semiconductor Index down over 6% intraday . Custom-silicon, GPU, and memory names now move together on a single data point about the pace of spending , and AXT — which makes the indium phosphide wafers used in AI data-center optical links — got caught in the downdraft despite no company-specific bad news.
• The Bull Case Rests on a $632 Million Bet on AI Demand. AXT recently raised $632.5 million to expand indium phosphide capacity , and carries a record $100 million indium phosphide backlog with profitability expected in Q2 . But export permit timing from China's Ministry of Commerce remains a key risk , and the company's trailing earnings per share remain negative at −$0.31 .
• Valuation Looks Stretched Against Fundamentals. AXTI's 52-week range spans an astonishing $1.67 to $143.16 , a gap that reflects hype as much as substance. Northland recently raised its price target to $125 , yet even that sits above today's price. With a negative-earnings company valued near $6 billion, shareholders are betting entirely on future AI-driven revenue that hasn't arrived yet — a bet that insider selling and sector volatility just made riskier.